Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate NRx Pharmaceuticals, Inc. before investing.

In this article, we go over a few key elements for understanding NRx Pharmaceuticals, Inc.’s stock price such as:

• NRx Pharmaceuticals, Inc.’s current stock price and volume
• Why NRx Pharmaceuticals, Inc.’s stock price changed recently
• Upgrades and downgrades for NRXP from analysts
• NRXP’s stock price momentum as measured by its relative strength

About NRx Pharmaceuticals, Inc. (NRXP)

Before we jump into NRx Pharmaceuticals, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.

Want to learn more about NRx Pharmaceuticals, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about NRx Pharmaceuticals, Inc..

NRx Pharmaceuticals, Inc.’s Stock Price as of Market Close

As of September 03, 2026, 10:56 AM, CST, NRx Pharmaceuticals, Inc.’s stock price was $3.490.

NRx Pharmaceuticals, Inc. is up 0.87% from its previous closing price of $3.460.

During the last market session, NRx Pharmaceuticals, Inc.’s stock traded between $3.425 and $3.500. Currently, there are approximately 37.65 million shares outstanding for NRx Pharmaceuticals, Inc..

NRx Pharmaceuticals, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

NRx Pharmaceuticals, Inc. Stock Price History

NRx Pharmaceuticals, Inc.’s (NRXP) price is currently up 0.29% so far this month.

During the month of September, NRx Pharmaceuticals, Inc.’s stock price has reached a high of $3.510 and a low of $3.380.

Over the last year, NRx Pharmaceuticals, Inc. has hit prices as high as $5.055 and as low as $1.620. Year to date, NRx Pharmaceuticals, Inc.’s stock is up 28.78%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused NRx Pharmaceuticals, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 02, 2026, there was 1 analyst who downgraded NRx Pharmaceuticals, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate NRx Pharmaceuticals, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on NRx Pharmaceuticals, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about NRx Pharmaceuticals, Inc. (NRXP) by visiting AAII Stock Evaluator.

Relative Price Strength of NRx Pharmaceuticals, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 02, 2026, NRx Pharmaceuticals, Inc. has a weighted four-quarter relative price strength of 7.04%, which translates to a Momentum Score of 75 and is considered to be Strong.

Want to learn more about how NRx Pharmaceuticals, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

NRx Pharmaceuticals, Inc. Stock Price: Bottom Line

As of September 3, 2026, NRx Pharmaceuticals, Inc.’s stock price is $3.490, which is up 0.87% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like NRx Pharmaceuticals, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.